First Time Loading...

Cullinan Oncology Inc
NASDAQ:CGEM

Watchlist Manager
Cullinan Oncology Inc Logo
Cullinan Oncology Inc
NASDAQ:CGEM
Watchlist
Price: 27.09 USD 7.08%
Updated: Apr 29, 2024

Income Statement

Earnings Waterfall
Cullinan Oncology Inc

Revenue
0 USD
Operating Expenses
-190.6m USD
Operating Income
-190.6m USD
Other Expenses
37.5m USD
Net Income
-153.2m USD

Income Statement
Cullinan Oncology Inc

Rotate your device to view
Income Statement
Currency: USD
Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023
Revenue
Revenue
0
N/A
19
N/A
19
N/A
19
N/A
19
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
Operating Income
Operating Expenses
(60)
(58)
(75)
(82)
(87)
(102)
(121)
(132)
(130)
115
(163)
(178)
(191)
Selling, General & Administrative
(17)
(19)
(23)
(28)
(29)
(32)
(36)
(41)
(38)
(41)
(42)
(43)
(42)
Research & Development
(43)
(39)
(51)
(54)
(58)
(70)
(85)
(92)
(92)
(120)
(120)
(135)
(148)
Other Operating Expenses
0
0
0
0
0
0
0
0
0
275
0
0
0
Operating Income
(60)
N/A
(39)
+36%
(56)
-45%
(63)
-12%
(68)
-8%
(102)
-50%
(121)
-18%
(132)
-9%
(130)
+2%
115
N/A
(163)
N/A
(178)
-9%
(191)
-7%
Pre-Tax Income
Interest Income Expense
1
0
0
0
0
1
1
3
7
11
16
19
22
Non-Reccuring Items
0
(1)
0
0
0
0
275
275
275
0
0
(0)
(0)
Total Other Income
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
0
0
0
1
0
Pre-Tax Income
(59)
N/A
(39)
+34%
(55)
-42%
(62)
-13%
(67)
-8%
(101)
-50%
155
N/A
146
-6%
151
+4%
126
-17%
(147)
N/A
(158)
-8%
(169)
-7%
Net Income
Tax Provision
0
0
0
0
0
20
(47)
(44)
(42)
(62)
4
2
14
Income from Continuing Operations
(59)
(39)
(55)
(62)
(67)
(82)
109
102
109
64
(142)
(157)
(155)
Income to Minority Interest
8
1
2
1
2
4
4
3
2
1
1
0
2
Net Income (Common)
(52)
N/A
(38)
+26%
(54)
-41%
(61)
-14%
(66)
-7%
(78)
-18%
113
N/A
105
-7%
111
+5%
65
-41%
(142)
N/A
(156)
-10%
(153)
+2%
EPS (Diluted)
-1.25
N/A
-0.92
+26%
-1.24
-35%
-1.41
-14%
-1.52
-8%
-1.74
-14%
2.43
N/A
2.31
-5%
2.38
+3%
1.6
-33%
-3.54
N/A
-3.65
-3%
-3.69
-1%

See Also

Discover More